145 related articles for article (PubMed ID: 32033340)
1. Prognosis-Predicting Model Based on [
Lee WK; Chong GO; Jeong SY; Lee HJ; Park SH; Ryu JM; Choi YS; Kang S; Koo YJ; Lee DH; Kong E; Lee SW
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32033340
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of intratumoral metabolic heterogeneity on F-18 fluorodeoxyglucose positron emission tomography/computed tomography in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy.
Chong GO; Lee WK; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS
Oncotarget; 2017 Oct; 8(52):90402-90412. PubMed ID: 29163839
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Pretreatment Metabolic PET Parameters in Cervical Cancer Patients With Metabolic Complete Response After Concurrent Chemoradiotherapy.
Son SH; Jeong SY; Chong GO; Lee YH; Park SH; Lee CH; Hong CM; Jeong JH; Lee SW; Ahn BC; Lee J
Clin Nucl Med; 2018 Sep; 43(9):e296-e303. PubMed ID: 30036243
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Prognostic Value of F-18 Pet Metabolic Parameters of Primary Tumors and Regional Lymph Nodes in Patients with Locally Advanced Cervical Cancer Who Are Treated with Concurrent Chemoradiotherapy.
Chong GO; Jeong SY; Park SH; Lee YH; Lee SW; Hong DG; Kim JC; Lee YS; Cho YL
PLoS One; 2015; 10(9):e0137743. PubMed ID: 26368542
[TBL] [Abstract][Full Text] [Related]
5. Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
Hong CM; Park SH; Chong GO; Lee YH; Jeong JH; Lee SW; Lee J; Ahn BC; Jeong SY
Cancer Imaging; 2019 Jun; 19(1):43. PubMed ID: 31234933
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Yilmaz B; Dağ S; Ergul N; Çermik TF
Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
[TBL] [Abstract][Full Text] [Related]
9. Prognostic values of ADC
Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z
J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907
[TBL] [Abstract][Full Text] [Related]
10. The PET-Derived Tumor-to-Liver Standard Uptake Ratio (SUV
Wang C; Zhao K; Hu S; Huang Y; Ma L; Li M; Song Y
Front Oncol; 2020; 10():1630. PubMed ID: 33014819
[No Abstract] [Full Text] [Related]
11. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.
Guler OC; Torun N; Yildirim BA; Onal C
Br J Radiol; 2018 Apr; 91(1084):20170552. PubMed ID: 29293366
[TBL] [Abstract][Full Text] [Related]
13. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-Analysis of the Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters in Patients with Locally Advanced Cervical Cancer Treated with Concomitant Chemoradiotherapy.
Han L; Wang Q; Zhao L; Feng X; Wang Y; Zou Y; Li Q
Diagnostics (Basel); 2021 Jul; 11(7):. PubMed ID: 34359345
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Impact of Pretreatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography SUVmax in Patients With Locally Advanced Cervical Cancer.
Cima S; Perrone AM; Castellucci P; Macchia G; Buwenge M; Cammelli S; Cilla S; Ferioli M; Ferrandina G; Galuppi A; Salizzoni E; Rubino D; Fanti S; De Iaco P; Morganti AG
Int J Gynecol Cancer; 2018 Mar; 28(3):575-580. PubMed ID: 29372911
[TBL] [Abstract][Full Text] [Related]
16. Prognostic nomogram for overall survival in stage IIB-IVA cervical cancer patients treated with concurrent chemoradiotherapy.
Tseng JY; Yen MS; Twu NF; Lai CR; Horng HC; Tseng CC; Chao KC; Juang CM
Am J Obstet Gynecol; 2010 Feb; 202(2):174.e1-7. PubMed ID: 19931041
[TBL] [Abstract][Full Text] [Related]
17. (
Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
[TBL] [Abstract][Full Text] [Related]
18. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
19. Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
Shim SH; Lee SW; Park JY; Kim YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2013 Jan; 128(1):54-59. PubMed ID: 23063760
[TBL] [Abstract][Full Text] [Related]
20. Improving the Prognostic Performance of SUV
Chong GO; Jeong SY; Lee YH; Park SH; Lee HJ; Lee SW; Hong DG; Lee YS
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32560143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
